UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027423
Receipt number R000031423
Scientific Title Qualitative and quantitative changes in skin T cells during treatments of skin disorders
Date of disclosure of the study information 2017/06/01
Last modified on 2019/05/23 19:46:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Qualitative and quantitative changes in skin T cells during treatments of skin disorders

Acronym

Skin disorders and skin T cells

Scientific Title

Qualitative and quantitative changes in skin T cells during treatments of skin disorders

Scientific Title:Acronym

Skin disorders and skin T cells

Region

Japan


Condition

Condition

inflammatory skin disorders, allergic skin disorders, collagen disease

Classification by specialty

Dermatology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To reveal the qualitative and quantitative changes in skin T cells and blood T cells during treatments of skin disorders and to find the specific changes of skin T cells according to treatment modalities.

Basic objectives2

Others

Basic objectives -Others

To reveal the changes of skin T cells before and after treatments

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Percentages of CCR7+CD62L+ central memory T cells, CCR7+CD62L- migratory memory T cells and CD69+CD103+ resident memory T cells in total T cells in lesional skin, non-lesional skin and blood before and after treatments.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

To collect skin biopsy specimens and blood samples after skin lesion is cleared by any kinds of treatments

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The skin disorder patients whose skin lesions disappeared after any kinds of treatments and who underwent skin biopsies for the sake of diagnosis before treatments.

Key exclusion criteria

None

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Manabu
Middle name
Last name Fujimoto

Organization

University of Tsukuba

Division name

Division of Medicine, Department of Dermatology

Zip code

305-8575

Address

1-1-1, Tennodai, Tsukuba-shi, Ibaraki, Japan

TEL

029-853-3128

Email

rwatanabe@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name Rei
Middle name
Last name Watanabe

Organization

University of Tsukuba

Division name

Division of Medicine, Department of Dermatology

Zip code

305-8575

Address

1-1-1, Tennodai, Tsukuba-shi, Ibaraki, Japan

TEL

029-853-3128

Homepage URL


Email

rwatanabe@md.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

Grants-in-Aid for Scientific Research

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Faculty of Medicine, University of Tsukuba

Address

1-1-1 Tennodai, Tsukuba, Ibaraki

Tel

+81298533128

Email

rwatanabe@md.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 06 Month 01 Day

Date of IRB

2007 Year 04 Month 18 Day

Anticipated trial start date

2017 Year 06 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 05 Month 21 Day

Last modified on

2019 Year 05 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031423


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name